Skip to main content

Dr. Francesca Polverino, MD PHD

Pulmonology (Pulmonary Disease Physician)

At a glance

Years since graduation
20
In the NPI registry since
2021

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2021Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pulmonary Disease Physician primary
    TX license 49268 · TX license 48169 · TX license 47790 · TX license 735407 · TX license 48514 · TX license 48856

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pulmonology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 29 payments worth $27,246 in total to this clinician.

By company
AstraZeneca Pharmaceuticals LP$13,854
Genzyme Corporation$13,184
Polarean, Inc.$87.74
Genentech, Inc.$55.97
Regeneron Healthcare Solutions, Inc.$36.55
Verona Pharma, Inc.$27.17
By type
Consulting Fee$22,370
Compensation for services other than consulting (speaking, faculty)$2,598
Travel and Lodging$1,300
Food and Beverage$978

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Nov 24, 2025Genzyme Corporation
Nov 24, 2025
Consulting Fee$9,750
Jan 4, 2025AstraZeneca Pharmaceuticals LP
Jan 4, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$4,028
Mar 31, 2025Genzyme Corporation
Mar 31, 2025
Compensation for services other than consulting (speaking, faculty)
DUPIXENT · Immunology
$2,598
Sep 22, 2025AstraZeneca Pharmaceuticals LP
Sep 22, 2025
Consulting Fee
FASENRA · Respiratory
$2,148
Sep 23, 2025AstraZeneca Pharmaceuticals LP
Sep 23, 2025
Consulting Fee
BREZTRI · Respiratory
$2,148
Sep 19, 2025AstraZeneca Pharmaceuticals LP
Sep 19, 2025
Consulting Fee$2,148
Oct 21, 2025AstraZeneca Pharmaceuticals LP
Oct 21, 2025
Consulting Fee
FASENRA · Respiratory
$1,611
Dec 17, 2025Genzyme Corporation
Dec 17, 2025
Travel and Lodging
travel to Philadelphia, PA
$597
Aug 27, 2025AstraZeneca Pharmaceuticals LP
Aug 27, 2025
Consulting Fee
FASENRA · Respiratory
$537
Sep 12, 2025AstraZeneca Pharmaceuticals LP
Sep 12, 2025
Travel and Lodging
BREZTRI · Respiratory · travel to Dallas, TX · in-kind
Company’s descriptionSpeaker Expenses
$284
All 12 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 17, 2025Genzyme Corporation
Dec 17, 2025
Travel and Lodging
travel to Philadelphia, PA
$597
Nov 24, 2025Genzyme Corporation
Nov 24, 2025
Consulting Fee$9,750
Oct 21, 2025AstraZeneca Pharmaceuticals LP
Oct 21, 2025
Consulting Fee
FASENRA · Respiratory
$1,611
Sep 23, 2025AstraZeneca Pharmaceuticals LP
Sep 23, 2025
Consulting Fee
BREZTRI · Respiratory
$2,148
Sep 22, 2025AstraZeneca Pharmaceuticals LP
Sep 22, 2025
Consulting Fee
FASENRA · Respiratory
$2,148
Sep 19, 2025AstraZeneca Pharmaceuticals LP
Sep 19, 2025
Consulting Fee$2,148
Sep 12, 2025AstraZeneca Pharmaceuticals LP
Sep 12, 2025
Travel and Lodging
BREZTRI · Respiratory · travel to Dallas, TX · in-kind
Company’s descriptionSpeaker Expenses
$284
Sep 12, 2025AstraZeneca Pharmaceuticals LP
Sep 12, 2025
Travel and Lodging
BREZTRI · Respiratory · travel to Dallas, TX · in-kind
Company’s descriptionSpeaker Expenses
$253
Sep 12, 2025AstraZeneca Pharmaceuticals LP
Sep 12, 2025
Travel and Lodging
BREZTRI · Respiratory · travel to Dallas, TX · in-kind
Company’s descriptionSpeaker Expenses
$166
Aug 27, 2025AstraZeneca Pharmaceuticals LP
Aug 27, 2025
Consulting Fee
FASENRA · Respiratory
$537
Mar 31, 2025Genzyme Corporation
Mar 31, 2025
Compensation for services other than consulting (speaking, faculty)
DUPIXENT · Immunology
$2,598
Jan 4, 2025AstraZeneca Pharmaceuticals LP
Jan 4, 2025
Consulting Fee
Company’s descriptionResearch Related Service
$4,028

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Other Pulmonology clinicians in Houston

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 13, 2026), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1760140420. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.